Tag: Healthcare

understanding-palliative-care-nsights-from-a-professional-nh-medlineplus-magazine

Understanding Palliative Care: Insights from a Professional | NIH MedlinePlus Magazine

Understanding Palliative Care: A Compassionate GuideIn the realm of healthcare, when serious or terminal illnesses strike, patients and their families are often left grappling with difficult decisions and overwhelming emotions. The vast array of...
news-26112024-175408

Reining in AI Use in Medicare Advantage: Biden Administration’s Plan

The Biden administration recently announced a series of proposed changes to private Medicare plans aimed at improving coverage, regulating the use of artificial intelligence, and ensuring access to behavioral health providers and additional benefits....
fda-approval-onis-rare-disease-therapy-lowers-triglycerides

FDA Approval: Ionis Rare Disease Therapy Lowers Triglycerides

Ionis Pharmaceuticals has achieved a significant milestone by obtaining FDA approval for their groundbreaking therapy, Tryngolza, designed to combat a rare and fatal genetic disease. This therapy targets patients suffering from familial chylomicronemia syndrome...
news-12082024-194709

Pfizer CEO’s Vision for Leading Cancer and Obesity Treatments

Albert Bourla, the CEO of Pfizer, is looking to shift the focus of the company from its successful COVID-19 vaccine and antiviral Paxlovid to new investments in drugs for cancer and obesity. While Pfizer's...
nyu-school-of-global-public-health-wins-stat-madness-vote

NYU School of Global Public Health Wins STAT Madness Vote

In a spirited celebration of scientific discovery, the recent STAT Breakthrough Summit East in Manhattan hosted a unique event that drew parallels to the excitement of March Madness. As basketball enthusiasts eagerly followed tournament...
dr-oz-advocates-for-a-in-congress

Dr. Oz Advocates for AI in Congress

Dr. Oz Champions AI in Congressional HearingIn a recent Senate Finance Committee confirmation hearing, Dr. Mehmet Oz, nominated by President Donald Trump to lead the Centers for Medicare and Medicaid, showcased his charisma and...
mass-general-brigham-vs-dana-farber-hospital-battle-unveiled

Mass General Brigham vs. Dana-Farber: Hospital Battle Unveiled

A battle is brewing behind the scenes in the world of healthcare, as the future of cancer care hangs in the balance. The clash between two prominent Massachusetts health care giants, Mass General Brigham...
unitedhealths-a-care-denials-lawsuit-allowed-to-proceed

UnitedHealth’s AI care denials lawsuit allowed to proceed

In a recent turn of events, Medicare Advantage beneficiaries who believe they were wrongfully denied care by UnitedHealth Group's algorithm have reason to celebrate. A judge ruled that their case can proceed, potentially shedding...
threat-to-pharmaceutical-public-private-partnerships-gileads-short-term-win

Threat to Pharmaceutical Public-Private Partnerships: Gilead’s Short-Term Win

In December 2024, a group of legal, medical, and public health experts united to file an amicus brief in support of the U.S. government in a groundbreaking patent lawsuit against Gilead Sciences Inc., a...
the-main-target-and-focus-the-article-focuses-on-key-figures-attending-the-jp-morgan-healthcare-conference-on-day-2new-title-highlights-from-jp-morgan-healthcare-conference-day-2

The Main Target and Focus: The article focuses on key figures attending the J.P....

Highlights from J.P. Morgan Healthcare Conference Day 2The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures making headlines and sharing insights that could shape the future...
narcan-over-the-counter-lifesaving-opioid-overdose-reversal-drug

Narcan: Over-the-Counter Lifesaving Opioid Overdose Reversal Drug

Narcan: The Groundbreaking Over-the-Counter Opioid Overdose Reversal DrugThe Food and Drug Administration has taken a monumental step in the fight against opioid overdoses by approving Narcan, a life-saving naloxone nasal spray, for over-the-counter use....
boosting-tuberculosis-research-funding-progress-made-but-still-short-of-goals

Boosting Tuberculosis Research Funding: Progress Made, But Still Short of Goals.

Progress in Tuberculosis Research Funding Still Falls Short of GoalsIn a recent report, it was revealed that despite reaching new heights in research and development (R&D) funding for tuberculosis, the total amount fell significantly...